Elicio Therapeutics, Inc.

NASDAQ:ELTX

Biotechnology

Healthcare
$2.70 -18.90%

-$0.89 today

Market cap
$51.48M
Beta
1.14
P/E (TTM)
-1.7
EPS (TTM)
-$2.21
52W Low $2.66High $16.00

Volume 0.41M

Average 0.34M

Balance Sheet

Inspect the capital base behind the business.

Assets

$25.86M

FY 2025 · Annual

-8.2% YoY

Liabilities

$24.23M

FY 2025 · Annual

-38.7% YoY

Equity

$1.64M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents88.76M7.8M12.89M17.62M18.56M
Short-term Investments00000
Net Receivables806K0000
Inventory00000
Other Current Assets379K36K895K1.28M73K
Total Current Assets91.25M10.72M16.35M20.69M19.31M
Property, Plant & Equipment (Net)4.44M8.5M7.28M6.19M5.08M
Goodwill00000
Intangible Assets00000
Long-term Investments723K617K0696K0
Tax Assets00000
Other Non-current Assets106K2.83M3.52M600K1.47M
Total Non-current Assets5.27M11.95M10.8M7.49M6.55M
Total Assets96.51M22.66M27.15M28.18M25.86M
Account Payables4.71M2.81M4.37M1.04M672K
Short-term Debt952K692K0901K0
Tax Payables00000
Deferred Revenue2.3M1.44M01.17M0
Other Current Liabilities2.06M444K2.57M2.31M2.53M
Total Current Liabilities11.3M6.87M9.76M11.52M8.11M
Long-term Debt00020.03M9.41M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities092K11K2.83M2.62M
Total Non-current Liabilities3.71M6.88M6.02M27.97M16.12M
Total Liabilities15.01M13.75M15.77M39.49M24.23M
Common Stock300K3K96K110K178K
Retained Earnings(215.14M)(107.01M)(142.2M)(194.1M)(233.67M)
Accumulated OCI(103K)0(197K)(175K)(127K)
Other Stockholders Equity226.01M0000
Minority Interest00000
Total Equity81.51M8.92M11.37M(11.31M)1.64M
Total Debt4.66M7.48M6.92M26.04M14.51M
Net Debt(84.09M)(316K)(5.98M)8.42M(4.05M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$14.9M
Other Current$1.3M
Total Current Assets$16.2M
PP&E (Net)$4.8M
Other Non-current$1.7M
Total Non-current Assets$6.5M
Total Assets$22.7M

Analysis

Selected assets total $22.7M for Latest. The largest visible component is Cash & Equivalents at $14.9M, about 65.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportAug 13, 2026
8-KCurrent reportAug 13, 2026
4Statement of changes in beneficial ownershipJul 17, 2026
4Statement of changes in beneficial ownershipJul 17, 2026
4Statement of changes in beneficial ownershipJul 17, 2026

How much cash does ELTX have?

Elicio Therapeutics, Inc. (ELTX) reported $18.56M in cash and equivalents in fiscal 2025.

How much debt does ELTX carry?

Elicio Therapeutics, Inc. (ELTX) reported $14.51M of total debt, with net debt of -$4.05M.